MYOV - Myovant Sciences Ltd
Close
26.98
-0.010 -0.037%
Share volume: 0
Last Updated: Thu 09 Mar 2023 10:01:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$26.99
-0.01
-0.04%
Summary score
44%
Profitability
50%
Dept financing
25%
Liquidity
27%
Performance
47%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-167.64%
Return on assets
-50.77%
Return on sales
0%
Return on invested capital
185.85%
Total debt ratio
196.1%
Debt ratio change over timeo
-0.58%
Current Ratio
5.9%
Quick Ratio
0%
Cash Position Ratio
5.84%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-69.83%
Return on assets
-41.17%
Return on sales
0%
Return on invested capital
167.35%
Total debt ratio
144.88%
Debt ratio change over timeo
-0.2%
Current Ratio
2.32%
Quick Ratio
0%
Cash Position Ratio
1.78%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
24.41%
Return on assets
-26.59%
Return on sales
0%
Return on invested capital
93.97%
Total debt ratio
206.26%
Debt ratio change over time
-0.16%
Current Ratio
2.07%
Quick Ratio
0%
Cash Position Ratio
1.61%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-234.38%
Return on assets
-119.65%
Return on sales
0%
Return on invested capital
-3.87%
Total debt ratio
-58.34%
Debt ratio change over time
-0.58%
Current Ratio
2.12%
Quick Ratio
0%
Cash Position Ratio
2.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MYOV | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -167.64% | 0% | 0% | 29.06% |
| Return on assets | -50.77% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 185.85% | 0% | 0% | 47.78% |
| Profitability | 50% | 0% | 25% | 31% |
| Total debt ratio | 196.1% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.58% | 0% | 0% | 19.02% |
| Dept financing | 25% | 0% | 0% | 48% |
| Current Ratio | 2.32% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.78% | 0% | 0% | 5.68% |
| Liquididy | 50% | 0% | 0% | 58% |
| Short-term ratios | MYOV | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -69.83% | 0% | 0% | -16.12% |
| Return on assets | -41.17% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 167.35% | 0% | 0% | 96.56% |
| Profitability | 50% | 0% | 50% | 14% |
| Total debt ratio | 144.88% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.2% | 0% | 0% | 0.09% |
| Dept financing | 25% | 0% | 0% | 39% |
| Current Ratio | 2.32% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 1.78% | 0% | 0% | 5.68% |
| Liquididy | 18% | 0% | 0% | 75% |